Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

IFN╬│-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.

Lo UG, Pong RC, Yang D, Gandee L, Hernandez E, Dang A, Lin CJ, Santoyo J, Ma S, Sonavane R, Huang J, Tseng SF, Moro L, Arbini AA, Kapur P, Raj GV, He D, Lai CH, Lin H, Hsieh JT.

Cancer Res. 2019 Mar 15;79(6):1098-1112. doi: 10.1158/0008-5472.CAN-18-2207. Epub 2018 Nov 30.

PMID:
30504123
2.

Intravascular large B-cell lymphoma with multi-organ failure presenting as a pancreatic mass: a case with atypical presentation and definite diagnosis postmortem.

Ronny FMH, Black MA, Arbini AA.

Autops Case Rep. 2017 Dec 8;7(4):30-36. doi: 10.4322/acr.2017.034. eCollection 2017 Oct-Dec.

3.

Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in Cancer.

Guerra F, Guaragnella N, Arbini AA, Bucci C, Giannattasio S, Moro L.

Front Oncol. 2017 Dec 1;7:295. doi: 10.3389/fonc.2017.00295. eCollection 2017. Review.

4.

Author response: Primary marginal zone lymphoma of the CNS presenting as a diffuse leptomeningeal process.

Gazzola DM, Arbini AA, Haglof K, Pacia SV.

Neurology. 2017 Mar 7;88(10):1007-1008. doi: 10.1212/WNL.0000000000003701. No abstract available.

PMID:
28265041
5.

Mitochondria and cancer chemoresistance.

Guerra F, Arbini AA, Moro L.

Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):686-699. doi: 10.1016/j.bbabio.2017.01.012. Epub 2017 Feb 1. Review.

6.

Primary marginal zone lymphoma of the cns presenting as a diffuse leptomeningeal process.

Gazzola DM, Arbini AA, Haglof K, Pacia SV.

Neurology. 2016 Sep 13;87(11):1180-2. doi: 10.1212/WNL.0000000000003097. Epub 2016 Aug 12. No abstract available.

PMID:
27521434
7.

[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.

Moro L, Arbini AA, Marra E, Greco M.

Int J Oncol. 2016 Jun;48(6):2722. doi: 10.3892/ijo.2016.3487. Epub 2016 Apr 14.

8.

Rapid and robust reversion to essential thrombocythemia on treatment with Decitabine in a case of hydroxyurea-induced t-MDS/AML.

Horton JD, Arbini AA, Perle MA, Raphael BG.

Clin Case Rep. 2015 Nov 15;4(1):46-50. doi: 10.1002/ccr3.431. eCollection 2016 Jan.

9.

Mitochondrial DNA depletion sensitizes cancer cells to PARP inhibitors by translational and post-translational repression of BRCA2.

Arbini AA, Guerra F, Greco M, Marra E, Gandee L, Xiao G, Lotan Y, Gasparre G, Hsieh JT, Moro L.

Oncogenesis. 2013 Dec 16;2:e82. doi: 10.1038/oncsis.2013.45.

10.

Bone marrow uptake of ferumoxytol: a preliminary study in healthy human subjects.

Storey P, Arbini AA.

J Magn Reson Imaging. 2014 Jun;39(6):1401-10. doi: 10.1002/jmri.24320. Epub 2013 Oct 10.

11.

Stress-related mitochondrial components and mitochondrial genome as targets of anticancer therapy.

Giannattasio S, Guaragnella N, Arbini AA, Moro L.

Chem Biol Drug Des. 2013 Jan;81(1):102-12. doi: 10.1111/cbdd.12057. Review.

PMID:
23253132
12.

Selective targeting of the mTORC1/2 protein kinase complexes leads to antileukemic effects in vitro and in vivo.

Schuster K, Zheng J, Arbini AA, Zhang CC, Scaglioni PP.

Blood Cancer J. 2011 Sep;1(9):e34. doi: 10.1038/bcj.2011.30. Epub 2011 Sep 2.

13.

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

Arbini AA, Greco M, Yao JL, Bourne P, Marra E, Hsieh JT, di Sant'agnese PA, Moro L.

Am J Pathol. 2011 May;178(5):2367-76. doi: 10.1016/j.ajpath.2011.01.050.

14.

Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria.

Moro L, Arbini AA, Hsieh JT, Ford J, Simpson ER, Hajibeigi A, Oz OK.

Endocrinology. 2010 Apr;151(4):1643-52. doi: 10.1210/en.2009-1450. Epub 2010 Mar 1.

PMID:
20194728
15.

Segmental tandem triplication of the MLL gene in an intravascular large B-cell lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cytogenetic, and molecular cytogenetic antemortem study.

Deisch J, Fuda FB, Chen W, Karandikar N, Arbini AA, Zhou XJ, Wang HY.

Arch Pathol Lab Med. 2009 Sep;133(9):1477-82. doi: 10.1043/1543-2165-133.9.1477.

PMID:
19722759
16.

Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.

Moro L, Arbini AA, Yao JL, di Sant'Agnese PA, Marra E, Greco M.

Cell Death Differ. 2009 Apr;16(4):571-83. doi: 10.1038/cdd.2008.178. Epub 2008 Dec 12.

17.
18.

Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.

Maftoun-Banankhah S, Maleki A, Karandikar NJ, Arbini AA, Fuda FS, Wang HY, Chen W.

Am J Clin Pathol. 2008 Feb;129(2):300-8. doi: 10.1309/4W2G3NDXUPG5J33N.

PMID:
18208811
19.

Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.

Moro L, Arbini AA, Yao JL, di Sant'Agnese PA, Marra E, Greco M.

Cancer Sci. 2008 Mar;99(3):553-63. doi: 10.1111/j.1349-7006.2007.00719.x. Epub 2007 Dec 27. Erratum in: Cancer Sci. 2014 Jul;105(7):932.

20.
21.
22.

Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience.

Vargas RL, Fallone E, Felgar RE, Friedberg JW, Arbini AA, Andersen AA, Rothberg PG.

Leuk Res. 2006 May;30(5):547-51. Epub 2005 Oct 24.

PMID:
16246419
23.

Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.

Moro L, Arbini AA, Marra E, Greco M.

J Biol Chem. 2005 Jun 10;280(23):22482-91. Epub 2005 Apr 1. Retraction in: J Biol Chem. 2014 Jun 20;289(25):17423.

24.

Angioleiomyoma of the patellar tendon sheath. Case report.

Lee SK, Arbini AA, Galloway MT.

Am J Knee Surg. 2001 Summer;14(3):178-80. No abstract available.

PMID:
11491429
25.

Mechanism underlying factor VII deficiency in Jewish populations with the Ala244Val mutation.

Hunault M, Arbini AA, Carew JA, Bauer KA.

Br J Haematol. 1999 Jun;105(4):1101-8.

PMID:
10554827
26.

Optimal dosing and triggers for prophylactic use of platelet transfusions.

Rinder HM, Arbini AA, Snyder EL.

Curr Opin Hematol. 1999 Nov;6(6):437-41. Review.

PMID:
10546800
27.

Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII.

Hunault M, Arbini AA, Carew JA, Peyvandi F, Bauer KA.

Blood. 1999 Feb 15;93(4):1237-44.

28.

The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies.

Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2825-9.

PMID:
9409261
29.
30.
31.

Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis.

Arbini AA, Mannucci PM, Bauer KA.

Thromb Haemost. 1995 Nov;74(5):1255-8.

PMID:
8607105
32.

Determinants of plasma factor VIIa levels in humans.

Eichinger S, Mannucci PM, Tradati F, Arbini AA, Rosenberg RD, Bauer KA.

Blood. 1995 Oct 15;86(8):3021-5.

33.

Molecular analysis of Polish patients with factor VII deficiency.

Arbini AA, Bodkin D, Lopaciuk S, Bauer KA.

Blood. 1994 Oct 1;84(7):2214-20.

34.

Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio?

Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM.

Thromb Haemost. 1993 Dec 20;70(6):921-4.

PMID:
8165612
35.

Effects of hirudin on activated partial thromboplastin time determined with ten different reagents.

Tripodi A, Chantarangkul V, Arbini AA, Moia M, Mannucci PM.

Thromb Haemost. 1993 Aug 2;70(2):286-8.

PMID:
8236136
36.

Markers of procoagulant imbalance in patients with localized melanomas and autoimmune disorders.

Tripodi A, Mannucci PM, Chantarangkul V, Bottasso B, Arbini AA, Della Bella S, Scorza R.

Br J Haematol. 1993 Aug;84(4):670-4.

PMID:
8217826

Supplemental Content

Loading ...
Support Center